Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1998 1
1999 1
2000 2
2002 2
2003 2
2007 1
2008 1
2009 4
2010 3
2011 3
2012 2
2013 3
2014 4
2015 5
2016 6
2017 7
2018 3
2019 5
2020 3
2021 6
2022 4
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

66 results

Results by year

Filters applied: . Clear all
Page 1
Metabolic lipid muscle disorders: biomarkers and treatment.
Angelini C, Pennisi E, Missaglia S, Tavian D. Angelini C, et al. Among authors: tavian d. Ther Adv Neurol Disord. 2019 Apr 22;12:1756286419843359. doi: 10.1177/1756286419843359. eCollection 2019. Ther Adv Neurol Disord. 2019. PMID: 31040882 Free PMC article. Review.
Salivary and serum irisin in healthy adults before and after exercise.
Missaglia S, Tommasini E, Vago P, Pecci C, Galvani C, Silvestrini A, Mordente A, Tavian D. Missaglia S, et al. Among authors: tavian d. Eur J Transl Myol. 2023 Jan 20;33(1):11093. doi: 10.4081/ejtm.2023.11093. Eur J Transl Myol. 2023. PMID: 36661485 Free PMC article.
Nanotechnology advances in brain tumors: the state of the art.
Invernici G, Cristini S, Alessandri G, Navone SE, Canzi L, Tavian D, Redaelli C, Acerbi F, Parati EA. Invernici G, et al. Among authors: tavian d. Recent Pat Anticancer Drug Discov. 2011 Jan;6(1):58-69. doi: 10.2174/157489211793979990. Recent Pat Anticancer Drug Discov. 2011. PMID: 21110824 Review.
Corrigendum: CDKN2A determines mesothelioma cell fate to EZH2 inhibition.
Pinton G, Wang Z, Balzano C, Missaglia S, Tavian D, Boldorini R, Fennell DA, Griffin M, Moro L. Pinton G, et al. Among authors: tavian d. Front Oncol. 2022 Nov 23;12:1081632. doi: 10.3389/fonc.2022.1081632. eCollection 2022. Front Oncol. 2022. PMID: 36505807 Free PMC article.
CDKN2A Determines Mesothelioma Cell Fate to EZH2 Inhibition.
Pinton G, Wang Z, Balzano C, Missaglia S, Tavian D, Boldorini R, Fennell DA, Griffin M, Moro L. Pinton G, et al. Among authors: tavian d. Front Oncol. 2021 Jul 1;11:678447. doi: 10.3389/fonc.2021.678447. eCollection 2021. Front Oncol. 2021. PMID: 34277422 Free PMC article.
66 results